🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Improving #Precision #Neuroscience on NASA 'Houston We Have a #Podcast'! Discussed Axonis Therapeutics, Inc. #project about to launch to ISS National Lab International Space Station National Laboratory on NG-19 #mission, through our MassChallenge 'Technology in #Space' prize nasa.gov/johnson/HWHAP/…

An interesting NASA podcast about a new experiment being conducted on the International Space Station. Axonis Therapeutics, Inc. CSO Shane Hegarty talks about microgravity and how it can be used for modeling neurological diseases. nasa.gov/johnson/HWHAP/…

Honor to discuss Axonis Therapeutics, Inc. project at International #Space Station National Laboratory on NASA NG-19 #mission. Leveraging #microgravity conditions International Space Station to test a rapid '3D mature #human #brain assembloid #model' of iPSC-derived #neurons & #glia, & a precision #therapy

Thanks for featuring Axonis Therapeutics, Inc. project ! Looking forward to the NASA NG-19 launch & appreciate the opportunity to conduct these studies through the ISS National Lab 'Technology in Space' prize with MassChallenge and The Boeing Company

When #NG19 launches from @NASA_Wallops next week, it'll carry multiple ISS National Lab-sponsored investigations. From new ways to treat #heartdisease to improving the efficiency of electronic devices like laptops, #science in space benefits life on Earth: ow.ly/6ewb50PkMvz

Science is launching to the International Space Station! 🚀 While you wait for August 1, read more about this science including studies of fire suppression, gene therapy, atmospheric monitoring, and other experiments, along with space-flown student artwork. go.nasa.gov/43futh0

Biotech #startup Axonis Therapeutics, Inc. is launching research to the International Space Station to help those on Earth affected by neurological disorders ranging from #Alzheimer’s and #Parkinson’s disease to epilepsy and migraines. #NG19 Details: ow.ly/bcbl50PmUf3

Think your idea or company has no business in space? Think again! Hear from Tech in Space winner, Axonis Therapeutics, Inc., about how #TeamBoeing and ISS National Lab are helping the biomedical startup improve treatments for neurological disorders. #NG19 youtube.com/watch?v=s1VAHB…

Gene therapy shows promise for treating paralysis and neurological conditions but the 3D models needed to test these therapies do not form in Earth’s gravity. Last week crew aboard the International Space Station conducted operations for Neuronix. More: go.nasa.gov/47NH3rt

I also got to meet CURE Epilepsy awardee Dr Shilpa Kadam in person! Shilpa has done INCREDIBLE preclinical research with #HIE & seizures — and she is truly Hope for HIE ☀️ personified. So grateful for her care & commitment to our community! She’s a force! ☀️🎉

#Welcomehome! When the #SpaceX Dragon capsule returned to Earth yesterday, it brought with it multiple #lifescience investigations designed to improve life here on the home planet. Read more to learn how #scienceinspace benefits life on Earth: ow.ly/M9Zn50Qlq0P

Want an even closer look at some of the groundbreaking #lifescience #research that returned to Earth yesterday? Check out our #photoessay to learn how #scienceinspace aims to improve the lives of patients right here on Earth: ow.ly/XzzX50Qlqty

Excited to participate in this fireside chat! #TechnologyInSpace award is special opportunity to push boundaries of #science in #space. MassChallenge #startups: conduct thought experiment on how #research might advance beyond what is possible on Earth by leveraging #microgravity

As Irish scientist, pushing #innovation in #space did not seem possible. But through Boeing/ISSNL 'Technology in Space' prize Axonis Therapeutics, Inc. made exciting #biotechnology advances. Grateful to MassChallenge for opportunity, & appreciate invite to share our story at inspiring ISSRDC

Join us in welcoming #WorldOrphanUSA's latest & greatest speaker additions: Rhythm, Al Freedman, Ana Mingorance, Shane Hegarty, Axonis Therapeutics, Inc., Tricha Shivas, FSR! Register with our discounted group rate: terrapinn.com/bookwodc_tw Inquire to speak: terrapinn.com/inquirewodc_tw

The Axonis team is very excited to announce we’ve raised a $115 million series A financing to support the development of novel neuromedicines targeting KCC2, including our lead program AXN-027 for epilepsy and pain. Read our press release: businesswire.com/news/home/2021…

Thrilled to share that the New York Stock Exchange celebrated our Series A financing on the trading floor after yesterday’s opening bell. Thanks, NYSE 🏛 for the recognition!

Did you know some viruses don’t cause illness but can instead be used to treat disease? Learn how #biotech startup Axonis Therapeutics, Inc. reprogramed a virus to treat neurological conditions like #Alzheimer’s in Upward, the official magazine of the ISS National Lab: ow.ly/FLsq50Uc5Ih

Aging Code Summit 11-Jun Longevity Global Christin Glorioso, MD PhD🏳️‍🌈 george church Jamie Heywood José Navarro-Betancourt Mahdi Moqri, PhD Michael Ringel, JD PhD Raiany Romanni Robert Kirk Ronjon Nag Shane Hegarty Bahareh Behrouz Tayo Sanders II Added to club's #event calendar #AgingResearch #Investment #longevity liveforever.club/events?selecte…